From Medscape UK

From The

National Cancer Research Institute (NCRI) 2018 Cancer Conference

November 04 - 06, 2018; Glasgow, United Kingdom

November 04 - 06, 2018 Glasgow, United Kingdom
  • NCRI 2019 Trial Confirms Low-Dose Radiation for Low-Risk Thyroid Cancer The safety and efficacy of low-dose radioactive iodine in patients with low-risk thyroid cancer has been confirmed by UK researchers in the longest-running trial of radiation treatment in this setting.

Conference News

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.